Exciting News: Think Rare Expands to Batten Disease (CLN2)
We are thrilled to announce that the Think Rare Program — our dedicated educational platform for rare pediatric diseases — is growing.
Following our educational work in Mucopolysaccharidoses (MPS), Metachromatic Leukodystrophy (MLD), and Alpha-Mannosidosis (AM), Think Rare will now expand to cover CLN2 (Neuronal Ceroid Lipofuscinosis Type 2), also known as Batten disease — a rare neurodegenerative disorder affecting children.
As part of this new segment, we will organize 4 live educational webinars in the second semester of 2026, bringing together expert voices to support healthcare professionals in the recognition, diagnosis, and management of CLN2.
Stay tuned — exact dates and registration links will be announced shortly.
Through the Think Rare Program, by equipping clinicians with the knowledge they need, we can make a difference for children and families navigating rare disease.
